POPNIL-DSR
Description
- Combination of Pantoprazole 40 mg (EC) and Domperidone 30 mg (SR)
- Dual-action relief from hyperacidity and gastric motility disorders
- Treats GERD, acid reflux, functional dyspepsia, and nausea
- Heals gastric and duodenal ulcers and protects the esophageal lining
- Promotes faster gastric emptying and reduces bloating and discomfort
- Sustained-release formulation for long-lasting therapeutic effect
- Ideal for chronic acid-related and digestive conditions
Composition
PENTOPRAZOLE-40 MG, DOMPERIDONE-30 MG,
Benefits
POPNIL-DSR provides comprehensive relief from both acid secretion and motility-related gastrointestinal issues. Pantoprazole helps in healing acid-related inflammation and ulcers in the stomach and esophagus, while Domperidone enhances gastric emptying and prevents symptoms like nausea and abdominal fullness. The sustained release of Domperidone ensures consistent action throughout the day, making POPNIL-DSR especially effective in treating chronic GERD and indigestion. With once-daily dosing, it improves patient compliance and quality of life.
Introduction
POPNIL-DSR is a powerful gastro-protective combination that contains Pantoprazole 40 mg (EC) and Domperidone 30 mg (SR). Pantoprazole is a proton pump inhibitor (PPI) that suppresses excess gastric acid production, while Domperidone is a dopamine receptor antagonist that improves gastrointestinal motility and prevents nausea, bloating, and vomiting. The dual-action formulation of POPNIL-DSR offers effective and sustained relief from gastroesophageal reflux disease (GERD), acid reflux, functional dyspepsia, and other acid-related digestive disorders. Its enteric-coated and sustained-release technology ensures optimal absorption and long-lasting efficacy.
